S
GEROTHERAPEUTIX develops gerotherapeutics targeting the underlying biological processes of aging to extend healthspan and reduce disease burden. The company utilizes proprietary MitoXcel geropeptides that focus on mitochondrial function to achieve systemic health improvements. This approach aims to deliver broad phenotypic healthspan benefits without targeting individual age-related diseases.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- GEROTHERAPEUTIX develops gerotherapeutics targeting the underlying biological processes of aging to extend healthspan and reduce disease burden. The company utilizes proprietary MitoXcel geropeptides that focus on mitochondrial function to achieve systemic health improvements. This approach aims to deliver broad phenotypic healthspan benefits without targeting individual age-related diseases.